This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Lucerno Dynamics. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: Paul Mozley: Innovator in In Vivo Measurement Systems
Introduction
Paul Mozley is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of medical technology, particularly in the area of radiopharmaceuticals. His innovative work focuses on improving the methods used for in vivo measurements of radiotracer concentrations in the human body.
Latest Patents
Paul Mozley holds a patent for an "In vivo measurement system and method for the localized measurement of radiotracer concentration in the body." This patent presents various embodiments of a device designed for in vivo measurements of radiopharmaceuticals used for diagnosis and monitoring of radiotherapy. The device features a cannula that includes a measurement chamber, a radiation detector, and a delivery lumen. This allows for the delivery of materials, such as radiotracers, to the patient while simultaneously measuring levels and concentrations of radioactive material in the patient's blood during and after administration. The device utilizes scintillation materials to detect emitted particles, which interact to release light that can be processed by optical detectors.
Career Highlights
Throughout his career, Paul has demonstrated a commitment to advancing medical technology. His work has the potential to enhance the accuracy and effectiveness of radiotherapy treatments, ultimately benefiting patient care. His innovative approach to in vivo measurement systems showcases his expertise and dedication to the field.
Collaborations
Paul Mozley has collaborated with esteemed colleagues, including Joshua G. Knowland and Ronald K. Lattanze. These partnerships have contributed to the development and refinement of his innovative technologies.
Conclusion
In summary, Paul Mozley is a distinguished inventor whose work in in vivo measurement systems has the potential to revolutionize the field of radiopharmaceuticals. His contributions are paving the way for improved diagnostic and therapeutic techniques in medicine.